Data Support First Approved Treatment for Acute Hepatitis C
https://www.profitableratecpm.com/f4ffsdxe?key=39b1ebce72f3758345b2155c98e6709c
(MedPage Today) — The direct-acting antiviral glecaprevir/pibrentasvir (Mavyret) was found to be highly effective and well-tolerated in adults with acute hepatitis C virus (HCV) infection, according to results from a multicenter phase IIIb trial. Among 286…
